Approval · Notice of Compliance 37063 · 2026

NUMELVI: Notice of Compliance 37063

Issued March 9, 2026

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 37063
Date: March 9, 2026
Company: Intervet Canada CorpKirkland, Quebec, Canada
Product type: Veterinary
Submission: New Drug Submission (NDS)
Submission class: Other

Products in this notice

Brand	DIN	Status today
NUMELVI	02566559	Marketed
NUMELVI	02566567	Marketed
NUMELVI	02566575	Marketed
NUMELVI	02566583	Marketed

Medicinal ingredients

ATINVICITINIB 4.8 MG per TAB
ATINVICITINIB 7.2 MG per TAB
ATINVICITINIB 21.6 MG per TAB
ATINVICITINIB 31.6 MG per TAB